Dietary supplement capsules marketed for relief of joint and body aches

  • Unapproved new drug found to contain undeclared meloxicam
  • Company: Anthony Trinh, 123Herbals LLC
  • Dietary Supplements, Drugs
  • FDA
  • January 7, 2026

Product details

  • Dietary supplement capsules marketed for relief of joint and body aches

Company announcement

Anthony Trinh, 123herbals LLC is recalling all lots of Silintan capsules due to the presence of undeclared meloxicam.

The affected Silintan capsules were distributed nationwide online at 123herbals.com.

Consumers should stop using this product and/or return to the place of purchase, discard, or contact their doctor.

Risk:

Exposure to meloxicam at doses exceeding the recommended maximum daily dose of 15mg/day, may result in a reasonable probability of serious life-threatening events such as blood clots, heart attack, and stroke. Patients also face risks of hypersensitivity reactions, gastrointestinal bleeding, ulceration, and perforation, as well as acute kidney injury, particularly in elderly. Dangerous drug-drug interactions may occur in patients on blood thinners or other NSAIDs, significantly increasing bleeding risk.

Impacted states: Nationwide

Products:

- Silintan Capsules (UPC code(s): N/A)

Contact

For more information, call (626) 656-3202 or email hello@123herbals.com.

View the original FDA notice

Browse all recalls

Related recalls